Ambalal Sarabhai Enterprises Ltd

NSE: AMBALALSA · BSE: 500009 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹40.07
Market cap: ₹307.1 Cr
Revenue (annual): ₹202.3 Cr
Net profit (annual): ₹17.80 Cr
P/E (TTM): 22.6×Sector 47.4×
Promoter holding: 31.36%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Debt & Borrowing 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Price Movement Clarification 1 Other Announcement 1 Capacity Expansion 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

12 Aug 2026 16:49 IST BSE

Financial Results

Ambalal Sarabhai Enterprises Q1 FY27 Results: Net Profit ₹4 Cr, Down 51.2% YoY

Ambalal Sarabhai Enterprises Ltd reported revenue from operations of ₹43.6 Cr (+8.2% YoY) and net profit of ₹4 Cr (-51.2% YoY) for Q1 FY27.

Key figure: Net profit ₹4 Cr · -51.2% YoY

Open full results → Read the filing ↗

21 May 2026 19:22 IST BSE

Financial ResultsAlfa Alert

Ambalal Sarabhai Enterprises Q4 FY26 Results: Turns Profitable, Net Profit ₹6.5 Cr

Ambalal Sarabhai Enterprises Ltd reported revenue from operations of ₹65.5 Cr (+1.1% YoY) and net profit of ₹6.5 Cr for Q4 FY26.

Key figure: Net profit ₹6.5 Cr

Open full results → Read the filing ↗

21 May 2026 19:21 IST BSE

Financial Results

Ambalal Sarabhai Enterprises Financial Results

Ambalal Sarabhai Enterprises approved its FY2026 audited financial results and recommended re-appointing top directors. The board also set July 30, 2026, for its 48th Annual General Meeting.

Read the filing ↗